Ditchcarbon
  • Contact
  1. Organizations
  2. Panagene Inc
Public Profile
Pharmaceutical Preparation Manufacturing
KR
updated 2 months ago

Panagene Inc Sustainability Profile

Company website

Panagene Inc., a leading biotechnology firm headquartered in South Korea (KR), has established itself as a key player in the molecular diagnostics industry since its founding in 2000. With a focus on innovative solutions for cancer diagnostics and personalised medicine, Panagene has developed a range of proprietary technologies that enhance the accuracy and efficiency of genetic testing. The company’s core offerings include advanced PCR-based assays and next-generation sequencing (NGS) products, which are distinguished by their high sensitivity and specificity. Panagene's commitment to research and development has positioned it at the forefront of the industry, earning recognition for its contributions to precision oncology. With a strong presence in both domestic and international markets, Panagene continues to drive advancements in molecular diagnostics, making significant strides in improving patient outcomes.

DitchCarbon Score

How does Panagene Inc's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

20

Industry Average

Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

34

Industry Benchmark

Panagene Inc's score of 20 is lower than 83% of the industry. This can give you a sense of how well the company is doing compared to its peers.

17%

Let us know if this data was useful to you

Panagene Inc's reported carbon emissions

Panagene Inc, headquartered in South Korea (KR), currently does not have available carbon emissions data for the most recent year. As such, there are no specific figures regarding their total emissions or breakdowns by Scope 1, 2, or 3. Additionally, the company has not outlined any reduction targets or commitments through initiatives such as the Science Based Targets initiative (SBTi) or other climate pledges. Without emissions data or reduction initiatives, it is unclear how Panagene Inc is addressing climate change within its operations. The absence of reported figures suggests a potential area for improvement in transparency and accountability regarding their environmental impact.

How Carbon Intensive is Panagene Inc's Industry?

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. Panagene Inc's primary industry is Pharmaceutical Preparation Manufacturing, which is very low in terms of carbon intensity compared to other industries.

How Carbon Intensive is Panagene Inc's Location?

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. This request for Panagene Inc is in KR, which we do not have grid emissions data for.

Panagene Inc's Climate Goals (2030 & 2050)

Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.

Panagene Inc has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
RE 100
Climate Action 100
Race To Net Zero
Reduction Actions

Compare Panagene Inc's Emissions with Industry Peers

Fulgent Genetics

US
•
Other business services (74)
Updated about 1 month ago

Agilent

US
•
Other services (93)
Updated 17 days ago

Genomic Health, Inc.

US
•
Pharmaceutical Preparation Manufacturing
Updated 3 months ago

Guardant Health

US
•
Pharmaceutical Preparation Manufacturing
Updated 23 days ago

MERCK Kommanditgesellschaft auf Aktien

DE
•
Pharmaceutical Preparation Manufacturing
Updated 9 days ago

Exact Sciences

US
•
Research and development services (73)
Updated 15 days ago

Let us know if this data was useful to you

Usage Policy

You're welcome to quote or reference data from this page, but please include a visible link back to this URL.

Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.

See our License Agreement for more details.

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers

Ditchcarbon
v251211.1
[email protected]+44 203 475 7875Ditch Carbon Ltd167-169 Great Portland StreetLondon W1W 5PF
UL Solutions verification badge
CDP logo
Gartner Cool Vendor 2025 badge
Available onAWS Marketplace logo
ProductPortalScope 3 Tool FunctionalityDataIntegrationsPricing
CustomersHaleonGrant ThorntonHikmaRead all stories
Use CaseSBTi-aligned baselining & progress trackingSupplier EngagementClimate-informed sourcing strategyEmission ReportingSustainable Finance
ResourcesCalculation MethodologyDocumentationBlogFAQOrganizationsIndustriesSBTI APITrust CentreChangelogWhitepaper
AboutTeamCareersLicense AgreementPrivacy